New Botanical Blend Launched for Women's Hormonal Care

OmniActive Health Technologies has launched Fenavari in India to advance women's hormonal health during midlife transitions. This proprietary botanical ingredient specifically supports women experiencing perimenopause, menopause, and post-menopause. Furthermore, the formulation blends standardized fenugreek (Trigonella foenum-graecum) and shatavari (Asparagus racemosus) extracts. Consequently, it offers a multi-pathway botanical approach to address vasomotor distress and hormonal fluctuations.

Clinical Evidence Supporting Women's Hormonal Health

A recent double-blind, placebo-controlled clinical trial evaluated the efficacy of this botanical blend in 138 Indian women. The study appeared in the peer-reviewed journal Women's Health Reports. Importantly, participants receiving the extract demonstrated over a 50 percent reduction in hot flashes and night sweats compared to placebo. Additionally, researchers noted marked improvements in endocrine markers, including increased serum estradiol and reduced follicle-stimulating hormone (FSH) levels. Moreover, the trial recorded significant improvements in mood, sleep quality, and anxiety scores by Day 84. Therefore, clinicians gain an evidence-backed botanical tool to manage midlife neuroendocrine symptoms through reproductive health management strategies.

Synergistic Phytochemical Mechanism and Standardization

The ingredient combines high-performance liquid chromatography (HPLC) standardized extracts containing active saponins. Specifically, it integrates shatavarin IV and protodioscin to target estrogenic pathways. As a result, the formulation enhances complementary phytoestrogenic and adaptogenic responses in target tissues. Furthermore, this combined extract avoids the fragmented approach of single-ingredient supplements. Because the average age of natural menopause in India is approximately 46 years, women spend nearly three decades post-menopause. Consequently, safe and validated non-hormonal solutions remain essential for long-term health, which can be further explored via specialized training in obstetrics, gynecology, and womens health.

Frequently Asked Questions

Q1: What active botanical ingredients comprise Fenavari?

Fenavari combines standardized extracts of fenugreek (Trigonella foenum-graecum) and shatavari (Asparagus racemosus) to deliver balanced phytoestrogenic support.

Q2: What clinical outcomes did the trial demonstrate?

The randomized trial demonstrated a greater than 50 percent reduction in vasomotor symptoms, elevated estradiol levels, reduced FSH, and improved sleep quality.

Q3: How does this formulation address perimenopausal and menopausal transitions?

The blend utilizes adaptogenic and phytoestrogenic mechanisms to stabilize hormonal fluctuations and alleviate anxiety and mood disturbances during midlife.

References

1. OmniActive launches nutraceutical for women’s hormonal health - ETHealthworld
2. Kashinath RN, Bhat VV, Morde A, Joshua L, Thomas JV. Dose-Dependent Efficacy of a Combined Standardized Extract of Fenugreek and Shatavari on Menopausal Symptoms: A Randomized, Double-Blind, Parallel, Placebo-Controlled Study. Women's Health Reports. 2026.
3. Ademola J, Ajgaonkar A, Debnath T, Debnath K, Langade J. Efficacy and safety of Shatavari root extract (Asparagus racemosus) for menopausal symptoms: A randomized, double-blind, three-arm, placebo-controlled study. Frontiers in Reproductive Health. 2025;7:1654503.